Showing results (41-50 of 223) with videos related to
Sort By:
Pageof 23
Reviews on Recent Clinical Trials|May 14, 2008
Immunotherapy of HCCTim F Greten, Michael P Manns, Firouzeh KorangyTherapeutic Advances in Gastroenterology|November 1, 2018
Current frontline approaches in the management of hepatocellular carcinoma: the evolving role of immunotherapyGagandeep Brar, Tim F Greten, Zachary J BrownOncoimmunology|December 18, 2012
Human Th17 cells in patients with cancer: Friends or foe?Tim F Greten, Fei Zhao, Jaba Gamrekelashvili, et al.Journal for Immunotherapy of Cancer|January 6, 2024
VB-111 (ofranergene obadenovec) in combination with nivolumab in patients with microsatellite stable colorectal liver metastases: a single center, single arm, phase II trialKelley Coffman-D'Annibale, Yuta Myojin, Cecilia Monge, et al.Cancer Immunology, Immunotherapy : CII|July 3, 2015
Hepatic myeloid-derived suppressor cells in cancerJosé Medina-Echeverz, Tobias Eggert, Miaojun Han, et al.Hepatology (Baltimore, Md.)|May 15, 2016
The case for immune-based approaches in biliary tract carcinomaAustin G Duffy, Oxana V Makarova-Rusher, Tim F GretenSeminars in Immunology|March 12, 2026
Chimeric antigen receptor therapy for hepatocellular carcinomaLorenz Kocheise, Mohamed-Reda Benmebarek, Mitchell Ho, et al.Digestive Diseases (Basel, Switzerland)|May 13, 2010
Immune responses in hepatocellular carcinomaFirouzeh Korangy, Bastian Höchst, Michael P Manns, et al.Expert Review of Gastroenterology & Hepatology|June 10, 2010
Immunotherapy of hepatocellular carcinomaFirouzeh Korangy, Bastian Höchst, Michael P Manns, et al.Cell|June 9, 2023
Medication effects on the gut microbiome in allo-HCTWelles Robinson, E Michael Gertz, Tim F Greten, et al.Pageof 23